BioCentury | Apr 10, 2006
Product Development

CF Foundation collaborations

CF Foundation collaborations The Cystic Fibrosis Foundation has invested in a wide variety of early-stage research activities by biotechs, including discovery tools, target identification studies and the development of specific therapeutics. Last month, the foundation...
BioCentury | Jul 27, 1998
Company News

Copernicus Gene management update

Copernicus Gene Systems Inc., Beachwood, Ohio Business: Gene/Cell therapy Hired: Thomas Barnish as VP of finance and CFO, formerly director of corporate finance for Medeva Pharmaceuticals Inc. WIR Staff...
BioCentury | Apr 6, 1998
Company News

Copernicus Gene, Targeted Genetics deal

...cancer and other indications, and may jointly seek a partner to develop the resulting products. Copernicus Gene Systems Inc....
BioCentury | Mar 2, 1998
Company News

Copernicus Gene, LXR deal

...involved in control of apoptosis with Copernicus's DNA compaction and expression technologies for gene delivery. Copernicus Gene Systems Inc....
BioCentury | Mar 2, 1998
Company News

Copernicus Gene board of directors update

Copernicus Gene Systems Inc., Cleveland, Ohio Business: Gene/Cell therapy Appointed: Robert Moen, VP of clinical and regulatory affairs of the Gene Therapy Unit of Baxter Healthcare Corp. WIR Staff...
BioCentury | Mar 2, 1998
Company News

Copernicus Gene management update

Copernicus Gene Systems Inc., Cleveland, Ohio Business: Gene/Cell therapy Promoted: Megan O'Neill Miller as VP of administration, formerly director of finance and administration WIR Staff...
BioCentury | Oct 20, 1997
Company News

Copernicus Gene other research news

...liver cancer. The technology is licensed from the Case Western Reserve University School of Medicine. Copernicus Gene Systems Inc....
BioCentury | Jun 16, 1997
Company News

Copernicus Gene other research news

...in nude mice was able to replicate in vivo as well, as assayed by PCR. Copernicus Gene Systems Inc....
BioCentury | Jun 9, 1997
Company News

Copernicus Gene, Inex deal

...delivery system. TCS is a combination of lipids and polymers designed to protect encapsulated DNA. Copernicus Gene Systems Inc....
BioCentury | Jun 2, 1997
Clinical News

Copernicus Gene regulatory update

...to the company, this boosts expression and increases the intensity of the gene therapy effect. Copernicus Gene Systems Inc....
Items per page:
1 - 10 of 10
BioCentury | Apr 10, 2006
Product Development

CF Foundation collaborations

CF Foundation collaborations The Cystic Fibrosis Foundation has invested in a wide variety of early-stage research activities by biotechs, including discovery tools, target identification studies and the development of specific therapeutics. Last month, the foundation...
BioCentury | Jul 27, 1998
Company News

Copernicus Gene management update

Copernicus Gene Systems Inc., Beachwood, Ohio Business: Gene/Cell therapy Hired: Thomas Barnish as VP of finance and CFO, formerly director of corporate finance for Medeva Pharmaceuticals Inc. WIR Staff...
BioCentury | Apr 6, 1998
Company News

Copernicus Gene, Targeted Genetics deal

...cancer and other indications, and may jointly seek a partner to develop the resulting products. Copernicus Gene Systems Inc....
BioCentury | Mar 2, 1998
Company News

Copernicus Gene, LXR deal

...involved in control of apoptosis with Copernicus's DNA compaction and expression technologies for gene delivery. Copernicus Gene Systems Inc....
BioCentury | Mar 2, 1998
Company News

Copernicus Gene board of directors update

Copernicus Gene Systems Inc., Cleveland, Ohio Business: Gene/Cell therapy Appointed: Robert Moen, VP of clinical and regulatory affairs of the Gene Therapy Unit of Baxter Healthcare Corp. WIR Staff...
BioCentury | Mar 2, 1998
Company News

Copernicus Gene management update

Copernicus Gene Systems Inc., Cleveland, Ohio Business: Gene/Cell therapy Promoted: Megan O'Neill Miller as VP of administration, formerly director of finance and administration WIR Staff...
BioCentury | Oct 20, 1997
Company News

Copernicus Gene other research news

...liver cancer. The technology is licensed from the Case Western Reserve University School of Medicine. Copernicus Gene Systems Inc....
BioCentury | Jun 16, 1997
Company News

Copernicus Gene other research news

...in nude mice was able to replicate in vivo as well, as assayed by PCR. Copernicus Gene Systems Inc....
BioCentury | Jun 9, 1997
Company News

Copernicus Gene, Inex deal

...delivery system. TCS is a combination of lipids and polymers designed to protect encapsulated DNA. Copernicus Gene Systems Inc....
BioCentury | Jun 2, 1997
Clinical News

Copernicus Gene regulatory update

...to the company, this boosts expression and increases the intensity of the gene therapy effect. Copernicus Gene Systems Inc....
Items per page:
1 - 10 of 10